A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Gotham Asset Management, LLC holds 21,033 shares of JAZZ stock, worth $2.58 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
21,033
Previous 6,000 250.55%
Holding current value
$2.58 Million
Previous $640,000 266.25%
% of portfolio
0.02%
Previous 0.01%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $1.51 Million - $1.75 Million
15,033 Added 250.55%
21,033 $2.34 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $326,371 - $373,597
3,140 Added 109.79%
6,000 $640,000
Q1 2024

May 15, 2024

SELL
$115.19 - $132.77 $110,927 - $127,857
-963 Reduced 25.19%
2,860 $344,000
Q4 2023

Feb 14, 2024

SELL
$114.26 - $136.0 $2.3 Million - $2.74 Million
-20,149 Reduced 84.05%
3,823 $470,000
Q3 2023

Nov 14, 2023

SELL
$122.0 - $145.31 $636,840 - $758,518
-5,220 Reduced 17.88%
23,972 $3.1 Million
Q2 2023

Aug 14, 2023

BUY
$122.5 - $147.16 $215,110 - $258,412
1,756 Added 6.4%
29,192 $3.62 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $467,858 - $560,361
3,492 Added 14.58%
27,436 $4.01 Million
Q4 2022

Feb 14, 2023

BUY
$129.72 - $159.85 $1.56 Million - $1.92 Million
11,998 Added 100.44%
23,944 $3.81 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $1.51 Million - $1.93 Million
11,946 New
11,946 $1.59 Million
Q3 2021

Nov 15, 2021

SELL
$128.64 - $184.79 $207,624 - $298,251
-1,614 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$160.2 - $186.42 $1.66 Million - $1.93 Million
-10,350 Reduced 86.51%
1,614 $287,000
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $1.53 Million - $1.76 Million
10,163 Added 564.3%
11,964 $1.97 Million
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $33,911 - $39,777
-241 Reduced 11.8%
1,801 $297,000
Q3 2020

Nov 16, 2020

SELL
$105.46 - $144.13 $2.06 Million - $2.81 Million
-19,521 Reduced 90.53%
2,042 $291,000
Q2 2020

Aug 13, 2020

BUY
$95.68 - $121.88 $2.06 Million - $2.63 Million
21,563 New
21,563 $2.38 Million
Q1 2020

May 15, 2020

SELL
$87.74 - $152.74 $378,598 - $659,073
-4,315 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$117.65 - $153.73 $993,554 - $1.3 Million
-8,445 Reduced 66.18%
4,315 $644,000
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $1.36 Million - $1.56 Million
-10,864 Reduced 45.99%
12,760 $1.64 Million
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $266,919 - $307,164
2,126 Added 9.89%
23,624 $3.37 Million
Q1 2019

May 15, 2019

SELL
$121.81 - $142.95 $2.2 Million - $2.58 Million
-18,055 Reduced 45.65%
21,498 $3.07 Million
Q4 2018

Feb 14, 2019

SELL
$115.94 - $166.74 $205,329 - $295,296
-1,771 Reduced 4.29%
39,553 $4.9 Million
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $6.65 Million - $7.46 Million
41,324 New
41,324 $6.95 Million
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $2.33 Million - $2.7 Million
-17,170 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $2.21 Million - $2.54 Million
-16,887 Reduced 49.58%
17,170 $2.31 Million
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $4.86 Million - $5.3 Million
34,057
34,057 $4.98 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.7B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track Joel Greenblatt's Portfolio

Track Joel Greenblatt Portfolio

Follow Joel Greenblatt (Gotham Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.